Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator -
The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...
View Post

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

2024 WATCH LIST Editor | Curator -
INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...
View Post

1000 Days Without Alcohol: Here’s What Happened

ALCOHOL Editor | Curator -
No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...
View Post

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

CLINICS Editor | Curator -
This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...
View Post

Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which are Best.

Uncategorized Editor | Curator -
Great Interview with Adam Tubero, Jake Slomowitz and Steve McCraken, Analyst's who Drink the Kool Aide for...
View Post

Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7. Pure Genius. Interview With Jonathan Sabbagh, CEO

CLINICS Editor | Curator -
Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy (KAP).
View Post

Guide to Miami Hedge Fund Week 2024

CONFERENCES Editor | Curator -
Each year, an intense series of alternative investment conferences take place in and around Miami. Here are the events for 2024...
View Post

Helping Ketamine Clinics Succeed. Beyond Marketing.

CLINICS Editor | Curator -
Beyond Marketing Helps Transform Mental Health, TMS & Ketamine Practices into Thriving Businesses. The way patients behave...
View Post

Lykos Therapeutics (formerly MAPS) Raises $100 Million. Cha-Ching.

PSYCH NEWS Editor | Curator -
MDMA therapy company Lykos raises $100M in Series A funding as it eyes FDA approval (MarketWatch). MAPS Public Benefit Corp. changes...
View Post

ATAI to Invest $50 Million in Beckley Psytech

2024 WATCH LIST Editor | Curator -
-Strategic investment in Beckley Psytech reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of...
View Post

Psychedelic Support Team! The Fireside Project.

CHARITY Editor | Curator -
Fireside Project was born at a unique moment in history. It was the spring of 2020. The pandemic was raging. Depression, anxiety,...
View Post

Blake Mycoskie Pledging $100 Million to Psychedelic Research (MarketWatch).

PSYCH NEWS Editor | Curator -
Donation is believed to be ‘biggest that we’ve ever seen in the psychedelics space.’ Quest for treatments for depression, PTSD centers...
View Post

Free Psychedelic Help is Just a Call or Text Away! Fireside Project.

CHARITY Editor | Curator -
Interview with Hanifa Nayo Washington and Joshua White of Fireside Project. September 24th, 2021. If you...
View Post
123...11Page 1 of 11

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator -
The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

2024 WATCH LIST Editor | Curator -
INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

ALCOHOL Editor | Curator -
No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.